Blog
7 min read

Fundamental Analysis Tools That Put Filings First

Fundamental analysis tools help investors test valuation, earnings quality, and management claims against SEC filings before committing capital with care.

A quarterly earnings call can make a company sound healthier than it is. A CEO may emphasize record demand, a "temporary" margin issue, or an adjusted earnings figure that excludes inconvenient costs. The useful question is not whether the story is compelling. It is whether the fundamental analysis tools used to assess it lead back to what the company formally reported.

For a business owner, research should establish three things: what the business earned, what it required to earn it, and what a reasonable buyer should pay for the future cash those earnings may produce. Everything else is secondary. Price targets, television commentary, and quarterly excitement can be useful context, but none substitutes for primary disclosures.

Why Most Research Tools Start Too Late

Many investor tools begin with a market price, a consensus estimate, or a ranking. That is efficient, but it can quietly put the conclusion ahead of the evidence. A low price-to-earnings ratio, for example, may reflect a durable bargain. It may also reflect earnings inflated by a one-time gain, underfunded liabilities, aggressive revenue recognition, or a business facing a structural decline.

The same problem appears in headline financial data. A dashboard can show five years of revenue growth in seconds. It may not show that growth came largely from acquisitions, that share count rose faster than income, or that operating cash flow lagged reported profits. Those details are usually present in the 10-K, 10-Q, footnotes, proxy statement, and cash flow statement. They simply require more work to connect.

Good research tools reduce that work without hiding the underlying record. They should make it easier to trace a metric to a filing, compare periods consistently, and see where a conclusion rests on judgment rather than fact.

Fundamental Analysis Tools: A Useful Hierarchy

Not every tool deserves equal weight. A disciplined process starts with source documents, then uses calculations and screens to organize the evidence. Valuation comes after the investor has formed a view of the business's economic quality.

SEC filings and earnings records

The annual report is the foundation. Ten years of 10-Ks can show whether margins, returns on capital, debt, share count, and free cash flow have held up across different conditions. Quarterly filings matter too, particularly when a company is changing rapidly or management is presenting a new explanation for weak results.

Read the financial statements together. The income statement tells you what management says it earned under accounting rules. The cash flow statement tests how much cash was actually generated. The balance sheet reveals the resources and obligations that may shape future returns.

Footnotes often carry the harder facts: pension assumptions, debt maturities, lease obligations, stock-based compensation, acquisition accounting, customer concentration, legal contingencies, and revenue-recognition policies. A clean headline number does not make these details immaterial.

Earnings-call transcripts are useful as a second record, not a replacement for filings. Compare management's public explanations with the language and risks later disclosed in formal reports. A difference does not automatically prove deception. Timing, legal standards, and legitimate uncertainty matter. But repeated optimistic framing that is unsupported by the filing is a governance signal worth documenting.

Financial-statement normalization

Raw reported numbers are not always comparable. Fundamental analysis requires separating recurring economics from events unlikely to repeat. Restructuring charges, asset sales, litigation settlements, tax benefits, and acquisition-related costs may all affect reported earnings.

Normalization is not permission to discard every expense that management labels "non-recurring." If a company records restructuring costs every few years, they may be a recurring cost of running that business. If acquisitions are central to its growth model, acquisition costs and dilution deserve attention rather than automatic exclusion.

A useful tool shows both the reported figure and the adjustment made, with a stated reason. The goal is not a prettier earnings number. It is a more conservative estimate of owner earnings across a full business cycle.

Quality and balance-sheet tests

A company can be inexpensive and still be a poor investment if its balance sheet leaves little room for error. Simple tests remain valuable because they force consistency. Current assets versus current liabilities, debt relative to operating income, interest coverage, retained earnings, and the relationship between receivables, inventory, and sales all help identify pressure beneath the surface.

Graham-style criteria are especially useful as filters. They are not universal laws. Asset-light software firms, banks, insurers, and capital-intensive manufacturers require different measures. Still, the discipline behind them applies broadly: demand evidence of financial strength, earnings durability, and an adequate margin between price and conservative value.

Return on invested capital also needs context. A high figure can indicate an exceptional business. It can also result from years of buybacks, a small asset base, temporary underinvestment, or accounting effects following acquisitions. The trend and the source matter more than a single screen result.

Intrinsic-value ranges and margin of safety

Valuation tools are often presented with more precision than they deserve. A discounted cash flow model can produce a value to the cent, but small changes in growth, margins, reinvestment, or discount rates can materially change the answer. That is not a reason to abandon valuation. It is a reason to use ranges.

Build a conservative range from several defensible inputs: normalized earnings or free cash flow, historical margins, capital needs, balance-sheet obligations, and a cautious view of future growth. Then compare that range with the market price. The resulting gap is not a forecast. It is a test of whether the price offers compensation for being wrong.

The margin of safety should widen when the business is cyclical, heavily indebted, dependent on a few customers, or difficult to understand. It can be narrower for a business with unusually stable cash generation and a strong balance sheet, though no company is immune to change.

Share-count and capital-allocation analysis

Per-share results determine what an owner actually receives. Net income can grow while each shareholder's claim stagnates if the company issues stock freely for acquisitions or compensation. Conversely, buybacks can create value when shares are repurchased below conservative intrinsic value and funded without weakening the balance sheet.

Review diluted shares outstanding over time, not merely the latest quarter. Then examine where cash went: dividends, repurchases, acquisitions, debt reduction, or internal investment. Capital allocation is one of the clearest records of management judgment because it eventually appears in cash movements and share count.

Corporate actions deserve separate attention. Spin-offs, divestitures, and mergers can obscure historical comparisons but can also create situations where price and underlying value temporarily diverge. A calendar of announced and completed spin-offs helps investors investigate these events before the usual coverage catches up.

Turn the Tools Into a Repeatable Process

The strongest toolset is not the largest one. It is the one you will use consistently. Begin with a screen for financial strength, profitability, valuation, and earnings history. Treat the output as a research queue, not a buy list.

For each candidate, review the multiyear financial record and identify the central economic question. Is growth organic? Are margins durable? Is debt manageable in a weaker year? Is the low valuation tied to a temporary problem or a deteriorating business? Then check the filings and management communications for evidence that challenges the initial answer.

Keep a short written record. Note the reported figure, the criterion applied, the result, and the filing language supporting it. This prevents a familiar failure of investment research: remembering the favorable thesis while losing track of the contrary evidence.

Tools such as Hety can shorten the mechanical work by screening long filing histories, calculating conservative value ranges, and placing executive statements beside formal disclosures. The investor should still inspect the evidence. Automation is useful when it preserves judgment, not when it substitutes for it.

What a Tool Cannot Decide for You

No screen can determine whether a new competitor will change an industry, whether a management team will allocate future cash intelligently, or whether a one-time setback will truly be temporary. Those are judgments. A sound process makes the assumptions visible and limits how much capital depends on any one of them.

Past financial performance is not predictive, and this material is not investment advice. The practical standard is simpler: before acting on a stock, be able to explain the business, the conservative value range, the principal risks, and the filing evidence that could prove your thesis wrong. If that explanation cannot survive a review of the record, more confidence is not the missing tool.

See the best undervalued deals on the market.

You are not going to read the balance sheet. You don’t have three hours per company to do it, and you shouldn’t have to.

Hety runs the value investor checklists you would have to run by hand, now expanded to the NYSE and Nasdaq:

  • Intrinsic value range — what the company is actually worth, not what the market says.
  • Graham tests — the same criteria Benjamin Graham used to separate real bargains from value traps.
  • A filings cross-check — what management claimed on the earnings call, verified against what they actually filed with the SEC.

No stock tips. No “hot picks.” Just the stocks where the price and reality have drifted apart — with the reasoning shown, so you can verify it yourself in minutes not hours.

See this week's most undervalued stocks — free

Free to start · no signup · no card · $29/month for the full list